Home
News
In Focus
Business
Metro
Nation
World
Sports
Feature
Opinion
View more »Opinion Columns
Wan LixinOpinion deputy editor of Shanghai Daily
Restaurants get off to a quick start thanks to game-changing policies
High service charges on event ticket refunds call for further regulation
Sunday
- Subscribe
Related News
Key barometer seen to fluctuate
By Ding Yining |
June 29, 2009, Monday
|
Print Edition
Print Edition
SHANGHAI'S key stock index will fluctuate in the near future, analysts said.
The Shanghai Composite Index added a combined 1.66 percent, or 47.72 points, in the past week and closed at 2,928.21 points last Friday.
"The index is not likely to climb too high after having hit a 12-month high on Thursday," said Yi Xiaobin, an analyst at Galaxy Securities.
"The ample capital in the market has been supporting the rise of most heavyweights and financial shares and investors are very likely to take profit this week. The index may likely stay between 2,800 and 3,050 points," he added.
Guilin Sanjin Pharmaceutical Co became the first company approved by the China Securities Regulatory Commission to launch an initial public offering after a nine-month break on new share sales.
The drug maker said it would launch an IPO today to raise US$88 million.
"Pharmaceutical companies and home appliance retailers did not perform well in the first half of the year, and they may do better in the future," Qian Xiangjin, an analyst at China CITIC Securities, wrote in a report.
"Investors should pay attention to brokerages, which are expected to benefit from the relaunch of IPOs after a long period of suspension," he added.
The Shanghai Composite Index added a combined 1.66 percent, or 47.72 points, in the past week and closed at 2,928.21 points last Friday.
"The index is not likely to climb too high after having hit a 12-month high on Thursday," said Yi Xiaobin, an analyst at Galaxy Securities.
"The ample capital in the market has been supporting the rise of most heavyweights and financial shares and investors are very likely to take profit this week. The index may likely stay between 2,800 and 3,050 points," he added.
Guilin Sanjin Pharmaceutical Co became the first company approved by the China Securities Regulatory Commission to launch an initial public offering after a nine-month break on new share sales.
The drug maker said it would launch an IPO today to raise US$88 million.
"Pharmaceutical companies and home appliance retailers did not perform well in the first half of the year, and they may do better in the future," Qian Xiangjin, an analyst at China CITIC Securities, wrote in a report.
"Investors should pay attention to brokerages, which are expected to benefit from the relaunch of IPOs after a long period of suspension," he added.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
